From: Incremental value of PET and MRI in the evaluation of cardiovascular abnormalities
 | 18F-FDG PET | NH4 | Rb-82 | 18F-FDG PET |
---|---|---|---|---|
Reason | Viability study | Perfusion study | Perfusion study | Tumour/inflammatory lesion assessment |
Diet | Low carbohydrate diet | Low carbohydrate diet | Low carbohydrate diet | High-fat, protein-permitted low carbohydrate diet for 24 hours Fasting for 6–12 hours |
Check blood glucose | If blood glucose < 110 mg/dL AND not diabetic, oral glucose loading |  |  | Unfractionated heparin loading |
 | If blood glucose 130–200 mg/dL OR diabetic, administer IV insulin depending on blood glucose level |  |  |  |
 | If blood glucose more than 200 mg/dL, notify physician (some institutes reschedule imaging) | If blood glucose more than 200 mg/dL, notify physician (some institutes reschedule imaging) |  |  |
Radiotracer administration | Administer 5–15 mCi of F-18 FDG when blood glucose below 150 mg/dL (preferable) | Administer 20 mCi NH4 | Administer 40 mCi Rb-82 | Administer 5–15 mCi of F-18 FDG |
18F-FDG during and after administration | Patient should remain seated or recumbent to avoid muscular uptake | Â | Â | Patient should remain seated or recumbent to avoid muscular uptake |
Start imaging | Wait 60Â minutes, then scan for 10Â minutes | Wait 10Â minutes and scan for 5Â minutes | Wait 10Â minutes and scan for 6:30Â minutes | Wait 60Â minutes, then scan for 10Â minutes |